Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial (Q40801133)
scientific article
Language:
Current Data About Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial
(P31) (Q13442814)
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

(P304) 1-7
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

(P407) (Q1860)

(P433) 1
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

(P478) 106
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

(P577) Thursday, January 1, 1987
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

(P921) (Q269829)

(Q632006)

(Q29496)
(P887)

(Q976388)
(P887)

(P1433) (Q564416)
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

(P1476) "Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial" (language: en)
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

(P2093) Karp JE
(P1545) 1
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

Merz WG
(P1545) 2
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

Hendricksen C
(P1545) 3
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

Laughon B
(P1545) 4
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

Redden T
(P1545) 5
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

Bamberger BJ
(P1545) 6
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

Bartlett JG
(P1545) 7
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

Saral R
(P1545) 8
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

Burke PJ
(P1545) 9
(P248)
(P698) 3538962
(P813) Saturday, September 23, 2017

other details
description scientific article

External Links
(P356) 10.7326/0003-4819-106-1-1
(P698) 3538962